A trial tested an enhanced recovery after surgery (ERAS) protocol in patients who underwent ambulatory transurethral resection (TURBT) of bladder cancer.

UConn Center on Aging researchers have published a new editorial in the journal Aging titled "Polyploidy-induced senescence: Linking development, differentiation, repair, and (possibly) cancer?" In ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

Investigators reported results from the first randomized controlled trial of office-based laser photocoagulation to standard TURBT for low-grade Ta bladder tumors.

Bacteria may be the next frontier in cancer treatment, according to a team led by researchers at Penn State that devised a new approach of creating bacteria-derived mixtures—or cocktails—to help fight ...

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...

Urine for a breakthrough — in a true medical milestone, UCLA surgeons completed the world’s first in-human bladder transplant. Dr. Nima Nassiri, a urologic transplant surgeon and director of the UCLA ...

June 12 (Reuters) - The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's (UR8.F), opens new tab drug to treat a type of bladder cancer, providing an alternative treatment as ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

Enhancing Cancer Care in Ukraine: Insights From Doctor Perspectives on Diagnosis and Treatment Quality Bladder cancer represents a significant public health concern worldwide, with its incidence and ...